Goodwin
Gozde Guckaya
- Deals
- 6
- Latest
- Jul 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 6 deals
Often works with
- Arman Oruc 4 deals together
- Malhar Naik 3 deals together
- Daniel Karelitz 3 deals together
- Julie Tibbets 3 deals together
- Kingsley L. Taft 3 deals together
- Kevin Walsh 3 deals together
- Graham Defries 2 deals together
- Timothy Holahan 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jul 2026 | Memo Therapeutics | – | Ipsen | Acquisition | Legal adviser to Memo Therapeutics AG (target) | Announced | 231.1 | Biotech | Ipsen acquisition of Memo Therapeutics |
| May 2026 | Perfuse Therapeutics | – | Bayer | Acquisition | Legal adviser to Perfuse Therapeutics (target) | Announced | 300.0 | Biotech+2 | Bayer acquisition of Perfuse Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Legal adviser to Synnovation Therapeutics (seller) | Announced | 2,000.0 | Biotech+2 | Novartis acquisition of Pikavation |
| Feb 2026 | Laysan Bio | – | Gannet BioChem | Acquisition | Legal adviser to Gannet BioChem (acquirer) | Announced | – | Pharma Services+2 | Gannet BioChem acquisition of Laysan Bio |
Deals where Gozde Guckaya is named on the firm's deal team, by the firm or the press.